Influenza outbreaks place a significant annual burden on the Australian healthcare system. There is well documented evidence that increasing rates of influenza vaccination, especially amongst high risk patients will decrease the number of confirmed cases of influenza, reduce hospital admissions, associated costs and death. Despite this, under usage of immunisation programs continues to be a significant public health concern with inadequate time to attend a venue for vaccination being identified as a significant contributor to less than ideal vaccination rates. The Royal Brisbane and Women's Hospital pharmacy service has input into ambulatory outpatient services, making it ideal for providing opportunistic vaccinations to patients in a hospital outpatient setting. The aim was to investigate the impact of such a service on increasing access for high-risk patients to receive their annual influenza vaccination.
Learn more
To watch Kim’s interview, visit the Clinical Excellence Showcase website.
For information about the project, visit their page on our Improvement Exchange.
Please subscribe to ‘Clinical Excellence Showcase’ wherever you digest your podcasts, rate and review on iTunes and follow us on social media: Facebook, Twitter and Instagram.